Patents Assigned to Rigel Pharmacauticals, Inc.
  • Methods and compositions for screening using diphtheria toxin constructs
    Patent number: 7566685
    Abstract: The invention relates to methods and compositions utilizing diphtheria toxin for screening purposes. The invention is particularly useful in screening for modulators of IgE synthesis, secretion and switch rearrangement.
    Type: Grant
    Filed: March 28, 2006
    Date of Patent: July 28, 2009
    Assignee: Rigel Pharmacauticals, Inc.
    Inventor: Todd M. Kinsella